
Ensign Peak Advisors’s Boston Scientific BSX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $134M | Buy |
1,251,478
+277,317
| +28% | +$29.8M | 0.23% | 90 |
|
2025
Q1 | $98.3M | Sell |
974,161
-561,778
| -37% | -$56.7M | 0.19% | 116 |
|
2024
Q4 | $137M | Sell |
1,535,939
-147,058
| -9% | -$13.1M | 0.24% | 80 |
|
2024
Q3 | $141M | Sell |
1,682,997
-164,395
| -9% | -$13.8M | 0.25% | 81 |
|
2024
Q2 | $142M | Sell |
1,847,392
-380,423
| -17% | -$29.3M | 0.26% | 77 |
|
2024
Q1 | $153M | Buy |
2,227,815
+294,081
| +15% | +$20.1M | 0.28% | 71 |
|
2023
Q4 | $112M | Buy |
1,933,734
+74,773
| +4% | +$4.32M | 0.22% | 98 |
|
2023
Q3 | $98.2M | Buy |
1,858,961
+401,718
| +28% | +$21.2M | 0.21% | 100 |
|
2023
Q2 | $78.8M | Sell |
1,457,243
-206,574
| -12% | -$11.2M | 0.16% | 119 |
|
2023
Q1 | $83.2M | Sell |
1,663,817
-175,908
| -10% | -$8.8M | 0.18% | 114 |
|
2022
Q4 | $85.1M | Buy |
1,839,725
+42,379
| +2% | +$1.96M | 0.19% | 114 |
|
2022
Q3 | $69.6M | Sell |
1,797,346
-144,633
| -7% | -$5.6M | 0.17% | 116 |
|
2022
Q2 | $72.4M | Buy |
1,941,979
+84,173
| +5% | +$3.14M | 0.17% | 117 |
|
2022
Q1 | $82.3M | Sell |
1,857,806
-64,901
| -3% | -$2.87M | 0.17% | 118 |
|
2021
Q4 | $81.7M | Buy |
1,922,707
+84,414
| +5% | +$3.59M | 0.16% | 132 |
|
2021
Q3 | $79.8M | Buy |
1,838,293
+659,331
| +56% | +$28.6M | 0.17% | 129 |
|
2021
Q2 | $50.4M | Sell |
1,178,962
-12,136
| -1% | -$519K | 0.1% | 176 |
|
2021
Q1 | $46M | Buy |
1,191,098
+114,288
| +11% | +$4.42M | 0.1% | 183 |
|
2020
Q4 | $38.7M | Buy |
1,076,810
+846,454
| +367% | +$30.4M | 0.09% | 201 |
|
2020
Q3 | $8.8M | Buy |
230,356
+28,933
| +14% | +$1.11M | 0.02% | 470 |
|
2020
Q2 | $7.07M | Sell |
201,423
-53,010
| -21% | -$1.86M | 0.02% | 504 |
|
2020
Q1 | $8.3M | Sell |
254,433
-254,149
| -50% | -$8.29M | 0.03% | 389 |
|
2019
Q4 | $23M | Buy |
+508,582
| New | +$23M | 0.06% | 265 |
|